Clinical Trials

Breast Carcinoma In Situ, Breast Neoplasms

NCT00788112 2017-08-07

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Phase 1 Completed

17 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01105312 2017-06-27

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Completed

28 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00897299 2017-05-17

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

900 enrolled

Breast Neoplasms

NCT00897845 2017-05-17

Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer

2,541 enrolled

Breast Neoplasms

NCT01156168 2017-05-17

Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

363 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00363012 2017-04-05

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Phase NA Completed

56 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00379509 2017-03-21

Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer

Phase 1 Completed

20 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00896857 2017-03-15

Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer

30 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00003854 2016-07-13

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Phase 3 Completed

4,590 enrolled

Breast Neoplasms

NCT00898976 2016-07-13

Biomarkers in Native American Women With Breast Cancer

120 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00664781 2016-05-24

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Phase 2 Completed

78 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Ovarian Neoplasms

NCT01004796 2016-02-29

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Breast Neoplasms

NCT00753207 2016-02-15

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

Phase 1 Completed

10 enrolled

Breast Neoplasms

NCT00900302 2016-02-10

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

98 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Penile Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Vulvar Neoplasms, Breast Neoplasms, Male

NCT00897338 2015-10-12

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

43 enrolled

Breast Neoplasms

NCT00898573 2015-10-02

Lapatinib Resistance in Patients With Breast Cancer

Withdrawn

Breast Neoplasms

NCT01424865 2015-05-08

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

1,874 enrolled

Breast Neoplasms

NCT02353988 2015-02-03

Arbre

Phase 2 Unknown

60 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00918216 2014-07-16

Spectroscopy of Breast Tissue

141 enrolled

Breast Neoplasms

NCT00949013 2014-05-26

S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313

1,600 enrolled

Breast Neoplasms

NCT01292083 2014-02-06

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Phase NA Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00671476 2014-01-10

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Phase NA Unknown

30 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00463034 2013-12-18

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

1,800 enrolled

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

120 enrolled

Breast Neoplasms

NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Phase 3 Completed

1,856 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00082979 2013-08-26

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

Phase 2 Unknown

60 enrolled

Breast Neoplasms

NCT00083018 2013-08-26

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer

Phase 2 Unknown

100 enrolled

Breast Neoplasms

NCT00918788 2013-08-22

Laser Spectroscopy of Breast Tissue Through a Needle Device

17 enrolled

Breast Neoplasms

NCT00897065 2013-07-10

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

957 enrolled